Induction of pneumonia in C57Bl/6 mice by intranasal inoculation with 10 6 cfu of Streptococcus pneumoniae resulted in sustained expression of interleukin (IL)-6 mRNA in lungs and increases in lung and plasma IL-6 concentrations. In IL-6-deficient (IL-60/0) mice, pneumonia was associated with higher lung levels of the proinflammatory cytokines tumor necrosis factor-a, IL-1b, and interferon-g and of the antiinflammatory cytokine IL-10 than in wild type (IL-6///) mice (all P õ .05). Also, the plasma concentrations of soluble tumor necrosis factor receptors were higher in IL-60/0 mice (P õ .05), while the acute-phase protein response was strongly attenuated (P õ .01). Lungs harvested from IL-60/0 mice 40 h after inoculation contained more S. pneumoniae colonies (P õ .05). IL-60/0 mice died significantly earlier from pneumococcal pneumonia than did IL-6/// mice (P õ .05). During pneumococcal pneumonia, IL-6 down-regulates the activation of the cytokine network in the lung and contributes to host defense.
Bacterial pneumonia remains a common disease, with an least in part produced locally in the lung at the site of infection, since in patients with unilateral pneumonia, IL-6 concentrations estimated incidence in the United States of 4 million cases per year, one-fifth of which require hospitalization [1, 2] . Despite in bronchoalveolar lavage fluid obtained from the infected lung have been found to be higher than in either lavage fluid from the availability of potent antimicrobial therapy, pneumonia is the sixth leading cause of death and the most frequent cause the uninfected lung or in plasma [7] . The role of IL-6 in the pathogenesis of bacterial pneumonia is unknown. Therefore, of death from infectious diseases in developed countries [1, 2] . Among patients with community-acquired pneumonia requirin the present study, we sought to determine the susceptibility of mice deficient for the IL-6 gene to pneumonia caused by ing hospitalization, the mortality rate can be as high as 25% [2 -4] . Streptococcus pneumoniae is the most frequently iso-S. pneumoniae. lated microorganism in patients with community-acquired pneumonia [1 -4] . Knowledge of the pathogenesis of pneumoMethods coccal pneumonia is important, not only because of its relatively high incidence but also because of the increasing occurAnimals. The induction of IL-6 during pneumonia was studied rence of resistance of S. pneumoniae to penicillin and other in C57Bl/6 mice (weighing 18-20 g ). The role of endogenously antimicrobial agents [5] .
produced IL-6 in the pathogenesis of pneumonia was determined Interleukin (IL)-6 is a cytokine that is frequently detected by comparing IL-6 gene-deficient (IL-60/0) mice with wild type in the circulation of patients with bacterial infections [6] , in-(C57Bl/6 x 129 Sv; IL-6///) mice (both types weighing 20-22 g). The generation of IL-60/0 mice has been described [9] .
cluding pneumonia [7, 8] . During pneumonia, IL-6 likely is at Induction of pneumonia. Pneumonia was induced as described [10, 11] . Briefly, S. pneumoniae serotype 3 was obtained from American Type Culture Collection (ATCC 6303; Rockville, MD). Pneumococci were grown to midlogarithmic phase at 37ЊC in 5% nasally. To assess whether this procedure per se induced an inDetermination of plasma and lung bacterial counts. At 40 h after administration of S. pneumoniae, blood was obtained asepflammatory response in the lungs, some mice were inoculated tically by retroorbital puncture. Then mice were sacrificed by cerviintranasally with 50 mL of isotonic saline only (i.e., without cal dislocation (5 mice/group), and lungs were removed aseptically bacteria).
and placed in 10 vol of sterile isotonic saline. Lungs were homogeSampling and assays. To assess the production of IL-6 during nized with a tissue homogenizer that was carefully cleaned and pneumonia, blood and lungs were collected before and 12, 24, 48, disinfected with 70% alcohol after each homogenization. Serial and 72 h after the administration of S. pneumoniae (6 mice per 10-fold dilutions in sterile isotonic saline were made of blood and time point). It should be noted that C57Bl/6 mice started dying lung homogenates, and 20-mL aliquots were plated onto sheep from pneumonia from 48 h after the administration of 10 6 cfu of blood agar plates and incubated for 18 h at 37ЊC and 5% CO 2 , S. pneumoniae. Therefore, data obtained at 72 h after inoculation after which colonies were counted. represent a selection of animals that were still alive. Blood and Statistical analysis. All values are expressed as mean { SE. lungs were also collected at 24 and 48 h after intranasal inoculation Two sample comparisons were made by the Wilcoxon test for with isotonic saline only (5 mice per time point). At the designated unpaired samples. Survival curves were compared with the logtime points, mice were anesthetized with inhaled methoxyflurane, rank test. P õ .05 was considered significant. blood was collected by cardiac puncture, and whole lungs were harvested for measurement of IL-6. Further, to assess the role of IL-6 in the production of other cytokines, blood and lungs were with alveolar cell necrosis, alveolar hemorrhage, fibrinous exunoelectrophoresis as described [14] . Myeloperoxidase (MPO) was date, and perivascular edema.
measured as an index of neutrophil infiltration of the lungs, exactly
Induction of IL-6 (figures 1, 2).
Neither normal mice nor as described [11, 15] .
mice 24 or 48 h after intranasal inoculation with sterile saline
IL-6 mRNA detection by reverse transcription-polymerase
had detectable IL-6 (ú0.10 ng/mL) in their circulation. Similar chain reaction. Lungs for RNA isolation were harvested before amounts of IL-6 were detectable in lung homogenates obtained and at 12, 24, 48, and 72 h after intranasal inoculation with S. pneumoniae and at 24 and 48 h after intranasal inoculation with isotonic saline. Lungs from 3 mice per time point were pooled. Total cellular RNA was extracted from snap-frozen lungs using a commercially prepared 5 M guanidinium isothiocyanate, acid phenol, and 2-mercaptoethanol solution (RNAzol-B; Bioteck, Friendswood, TX). Total cellular RNA (1 mg) was reverse-transcribed using 2.5 U of murine leukemia virus reverse transcriptase and 0.05 nmol of oligo(dT) (Perkin-Elmer Cetus, Norwalk, CT). cDNA was amplified with 2.5 U of DNA polymerase (AmpliTaq; Perkin-Elmer Cetus) and oligonucleotide primers specific for bactin [10] or IL-6 (Stratagene, La Jolla, CA) using 35 cycles of DNA amplification on a thermocycler (PTC-100; MJ Research, Watertown, MA). Each cycle included denaturation at 95ЊC, reannealing of primer and fragment at 55ЊC, and primer extension at 72ЊC. The primers used for IL-6 were 456-GACAAAGCCAGA-GTCCTTCAGAGAG-480 (sense) and 663-CTAGGTTTGCCG- Figure 1 . Induction of IL-6 during pneumococcal pneumonia:
AGTAGATCTC-684 (antisense) [16] . Then 15 mL of the 100-mL mean ({ SE) plasma and lung concentrations of IL-6. At time 0, reaction mixture was fractionated on a 1% agarose gel. Samples mice were inoculated with 50 mL (10 6 cfu) of Streptococcus pneumowere electrophoresed at 100 V for 1.5 h and stained with ethidium niae. At each designated time point, 6 mice were sacrificed, and their plasma and lungs were harvested for measurement of IL-6.
bromide (1 mg/mL).
/ 9d2f$$au22 06-24-97 13:35:48 jinfa UC: J Infect ure 3 and table 1 ). As expected, IL-6 could not be detected in plasma or lungs of IL-60/0 mice during pneumonia. In addition, no IL-6 mRNA was found in the lungs of these mice after administration of S. pneumoniae (data not shown). In IL-6/// mice, plasma IL-6 levels were 0.59 { 0.10 ng/mL after 24 h and 3.76 { 1.50 ng/mL after 40 h; lung IL-6 concentrations were 50.74 { 4.91 and 228.37 { 41.57 ng/g, respectively. Lung TNF levels were 3-to 4-fold higher in IL-60/0 mice than in IL-6/// mice (P õ .05). In plasma, TNF remained undetectable (õ0.03 ng/mL) in all but 1 IL-6/// mouse. By contrast, all IL-60/0 mice had detectable plasma TNF levels at 40 h after inoculation (P õ .01 vs. IL-6/// mice). Lung IL-1b and IFN-g levels were higher in IL-60/0 mice at 24 h after inoculation (P õ .05). In plasma, IL-1b remained undetectable (õ0.12 ng/mL) in all but 2 mice. Plasma IFN-g was higher in IL-60/0 mice at 24 h after induction of pneumonia (P õ .05). Lung levels of the antiinflammatory cytokine IL-10 were higher in IL-60/0 mice at 40 h after inoculation (P õ .05), while IL-10 remained undetectable (õ0.12 ng/mL) IL-6/// mice (P õ .05).
mice/group/time point. * P õ .05, Wilcoxon test, vs. IL-6/// mice.
The acute-phase protein response was strongly attenuated in IL-60/0 mice (P õ .01 vs. IL-6/// mice). Lung MPO activity after inoculation than did IL-6/// mice (608 { 346 1 10 7 was higher in IL-60/0 mice than in IL-6/// mice (P Å .01). and 112 { 59 1 10 7 cfu, respectively; P õ .05). From all Bacterial clearance. IL-60/0 mice had Ç6-fold more S. pneumoniae colonies isolated from lung homogenates at 40 h mice, S. pneumoniae could be cultured from blood. Although / 9d2f$$au22 06-24-97 13:35:48 jinfa UC: J Infect the mean number of colonies was much higher in IL-60/0 injection of endotoxin, inhibition of proinflammatory cytokines mice, the difference with IL-6/// mice was not significant may be beneficial [17, 18] . In such models, high levels of due to large interindividual variation (182 { 109 1 10 4 and proinflammatory cytokines appear in the circulation, and inhibi-13 { 3 1 10 4 /mL, respectively; nonsignificant).
tion of their systemic effects confers protection against tissue Survival ( figure 4) . Survival studies were performed in 16 injury and lethality. However, these models of systemic chal-IL-60/0 and 16 IL-6/// mice. Mortality was assessed every lenges do not provide insight into the potential beneficial effects 12 h. IL-60/0 mice succumbed significantly earlier from pneuof proinflammatory cytokines at the site of an infection. We mococcal pneumonia than did IL-6/// mice (P õ .05). Eight recently found that local production of TNF within the lung is IL-60/0 mice were dead at 48 h after inoculation versus 2 important for host defense in this murine model of pneumococ-IL-6/// mice; all IL-60/0 mice had died by 60 h, at which cal pneumonia [11] , while IL-10 produced in lungs hampers time 6 IL-6/// mice were still alive.
host defense [10] . In accord, neutralization of IL-10 in mice with pneumonia caused by Klebsiella pneumoniae was associated with a decrease in Klebsiella colonies in lungs and an Discussion increase in survival [19] . During overwhelming immune activation, especially in the In models of systemic inflammation induced by bolus adminabsence of a localized infectious source such as after bolus istration of endotoxin, TNF is a mediator of toxicity and death [17] , while IL-10 is protective [18] (i.e., completely the opposite of their respective roles in models of gram-negative [19, 20] and gram-positive [10, 11] pneumonia, even though, in such models, blood cultures are positive). It should be noted, however, that in endotoxin-challenge models, lipopolysaccharide is injected directly into the circulation, while during pneumonia, bacteria likely are shed gradually or intermittently from the source of the infection, which apparently does not result in detectable cytokine levels in the circulation [10, 11] (present data). Hence, animal studies of pneumonia and systemic endotoxin effects represent two completely different entities, the former being more clinically relevant. Although IL-6 is not an important mediator of endotoxininduced inflammatory responses [9, 21 -23] , recent studies indicate that this cytokine may have a significant role in host (wild type) mice. There were 16 mice/group. IL-60/0 mice died significantly earlier than IL-6/// mice (P õ .05, log-rank test). [9, 24] . Further, IL-6 -deficient mice demonstrated enhanced / 9d2f$$au22 06-24-97 13:35:48 jinfa UC: J Infect mortality after intraperitoneal administration of live Eschecreased number of bacterial colonies in IL-60/0 mice was associated with reduced survival time in these animals. It has richia coli, which is associated with increased bacterial numbers in organs during the course of this infection [23] . The been postulated that the absence of an adequate neutrophilic response in IL-6-deficient mice contributes to the increased objective of the present study was to determine the role of endogenous IL-6 in the pathogenesis of pneumococcal pneususceptibility to L. monocytogenes and E. coli infection [23, 24] . In our study, IL-60/0 mice had enhanced pulmonary MPO monia, the most frequent manifestation of community-acquired pneumonia.
activity, as determined 40 h after inoculation with S. pneumoniae. Although neutrophil numbers were not actually counted The absence of an IL-6 response in IL-60/0 mice was associated with enhanced induction of both agonist and antagonist in our study, it has previously been shown that MPO activity corresponds well with the number of neutrophils in tissue secmembers of the cytokine network. Some of these findings were anticipated from previous studies. Indeed, IL-6 has been contions of inflamed lungs [30] . Conceivably, the elevated lung TNF levels in IL-60/0 mice contributed to increased neutrophil sidered an antiinflammatory cytokine by virtue of its ability to inhibit endotoxin-induced TNF and IL-1 production by monoinflux, since TNF is considered to play a significant role in this characteristic inflammatory response [20] . nuclear cells in vitro [25, 26] and to reduce TNF release in endotoxemic mice in vivo [25] . In accord, endotoxin-treated
In comparison with other cytokines, IL-6 has been reported most consistently in the circulation of septic patients [31] . Until IL-60/0 mice produce 3 times more TNF than wild type controls [22] . However, administration of IL-6 to cancer patients recently, IL-6 was merely considered a marker for the severity of the bacterial challenge, rather than a significant player in results in an increase in the plasma levels of soluble TNFR-I [27]. Therefore, the enhanced release of soluble TNFR-I and the pathogenesis of bacterial infection. This and other studies [9, 23, 24] indicate that the role of IL-6 in host defense against TNFR-II in IL-60/0 mice was unexpected. Interestingly enough, IL-60/0 mice also had increased pulmonary levels of bacteria is more important than previously recognized. Our study does not elucidate the mechanisms by which IL-6 con-IL-10, a pleiotropic cytokine known to inhibit the production of proinflammatory cytokines under various in vitro and in tributes to antibacterial mechanisms or activation of inflammatory responses. Considering the limited (direct) effects of ILvivo conditions [18] . Hence, it should be noted that IL-60/0 mice had elevated proinflammatory cytokine levels despite con-6 in various in vitro systems, it is conceivable that IL-6 is involved indirectly and influences the activity of mediators currently elevated IL-10 concentrations.
acting more directly on inflammatory processes. Nonetheless, The mechanism by which the absence of an IL-6 response these results indicate that neutralization of IL-6 activity in resulted in enhanced release of soluble TNF receptors and humans, as has been propagated for some diseases [32, 33] , IL-10 remains to be elucidated. Possibly, the elevated TNF may hamper a specific resistance against bacterial infections. levels in IL-60/0 mice contributed to these exaggerated antiinPneumococcal pneumonia is the most common communityflammatory responses, since TNF can induce release of its acquired pneumonia. In our study, IL-6 was produced locally receptors and of IL-10 in humans, and anti-TNF treatment of within the lung during pneumonia caused by S. pneumoniae. endotoxemic primates abrogates the appearances of soluble Endogenous IL-6 played a major role in the induction of the TNF receptors and IL-10 [28, 29] .
cytokine network within the lung, controlling the activation of TNF was not detectable in plasma of wild type mice during both agonist and antagonist mediators during pneumonia. The pneumonia. Although we cannot exclude the possibility that net effect of IL-6 was protective, reducing the growth of pneu-TNF was detectable in plasma at early time points after inoculamococci and prolonging survival. Thus, IL-6 was an important tion, we consider this unlikely, since during pneumonia TNF mediator of inflammation within lungs during pneumococcal is produced within lungs, and the highest lung TNF levels are pneumonia. According to our findings and those of earlier studfound after §24 h [11] . Rather, these data suggest that TNF ies addressing the role of cytokines in the pathogenesis of production is compartmentalized within lungs and that plasma bacterial pneumonia [10, 11, 19, 20] , it becomes increasingly TNF levels are a weak reflection of lung TNF concentrations.
clear that local inflammation, facilitated directly or indirectly The acute-phase protein response was markedly reduced in by proinflammatory cytokines, is essential for local defense IL-60/0 mice with pneumococcal pneumonia. These data exagainst bacteria. Neutralization of proinflammatory cytokines tend previous studies with IL-60/0 mice, demonstrating that in patients with bacterial infections may therefore be potentially IL-6 is not required to generate an acute-phase protein response hazardous and may be one reason, among others, why clinical to endotoxin but is an important mediator of acute-phase protrials with strategies directed against TNF, based primarily tein release during sterile inflammation induced by subcutaneon animal models in which bacteria or their products were ous injection of turpentine and during infection with L. monocyadministered as a bolus, have not been successful [17, 34] . togenes [9, 22] .
Significantly more pneumococci were recovered from lungs
